Scroll Top

Gen’s 40th Anniversary Recollections & Predictions

To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections, impressions, and insights on the biotechnology industry and the life sciences. We also queried them on what they believe the future might look like for biotechnology. We sought the thoughts and opinions of those working in areas directly or indirectly related to one or more of GEN’s editorial pillars, that is, drug discovery, OMICS, gene editing, cancer research, infectious diseases, artificial intelligence and data management, translational medicine, and financial analysis and venture capital.

We asked them, for example, what stands out about the past 40 years of biotech, what has been the biggest change in the biotech industry, what is the most exciting recent development in this industry, and what are their hopes for the future of biotech. The GEN team is most appreciative of the range of thoughtful responses that we received. We are sure that you will be pleased when you read the following page

40th Anniversary Recollections & Predictions

Related Posts